Sylvie Mazoyer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sylvie Mazoyer has a total of 162 co-authors. Here are the top co-authors by number of shared publications:
- Adrien Briaux
Oncogenetic Laboratory, Departement of Genetics, Curie Institute, 26 Rue d’Ulm, 75005 Paris, France
1 shared publication - Agnès Hardouin
Laboratoire de Biologie et de Génétique du Cancer, CLCC François Baclesse, INSERM 1079 Centre Normand de Génomique et de Médecine Personnalisée, F-14076 Caen, France
1 shared publication Alberto Fernández-Jaén
Department of Paediatric Neurology, Hospital Quirónsalud, School of Medicine, Universidad Europea de Madrid, Cell Biology Department, Madrid, Spain; School of Biological Sciences, Universidad Complutense de Madrid, Madrid, Spain
1 shared publicationAlessandro Bruselles
Molecular Medicine and Oncology, Istituto Superiore di Sanità, Rome, Italy
1 shared publicationAlessandro Mussa
Department of Public Health and Pediatrics, University of Turin, Turin, Italy
1 shared publicationAlexander Hustinx
Institute for Genomic Statistics and Bioinformatics, Medical Faculty, University Bonn, Bonn, NRW, Germany
1 shared publication
Latest Publications
- Open Access
- 19 June 2026
- Published by Elsevier in Genetics in Medicine
- Vol. 28 (10) , 102632
Expanding the clinical spectrum of RNU4ATAC-opathies: More frequent and diverse than assumed
- 19 June 2026
- Published by Elsevier in Genetics in Medicine
- Vol. 28 (10) , 102632
Open AccessExpanding the clinical spectrum of RNU4ATAC-opathies: More frequent and diverse than assumed
- Open Access
5′ Region Large Genomic Rearrangements in the BRCA1 Gene in French Families: Identification of a Tandem Triplication and Nine Distinct Deletions with Five Recurrent Breakpoints
Background: Large genomic rearrangements (LGR) in BRCA1 consisting of deletions/duplications of one or several exons have been found throughout the gene with a large proportion occurring in the 5′ region from the promoter to exon 2. The aim of this study was to better characterize those LGR in French high-risk breast/ovarian cancer families. Methods: DNA from 20 families with one apparent duplication and nine deletions was analyzed with a dedicated comparative genomic hybridization (CGH) array, high-resolution BRCA1 Genomic Morse Codes analysis and Sanger sequencing. Results: The apparent duplication was in fact a tandem triplication of exons 1 and 2 and part of intron 2 of BRCA1, fully characterized here for the first time. We calculated a causality score with the multifactorial model from data obtained from six families, classifying this variant as benign. Among the nine deletions detected in this region, eight have never been identified. The breakpoints fell in six recurrent regions and could confirm some specific conformation of the chromatin. Conclusions: Taken together, our results firmly establish that the BRCA1 5′ region is a frequent site of different LGRs and highlight the importance of the segmental duplication and Alu sequences, particularly the very high homologous region, in the mechanism of a recombination event. This also confirmed that those events are not systematically deleterious.
Open Access5′ Region Large Genomic Rearrangements in the BRCA1 Gene in French Families: Identification of a Tandem Triplication and Nine Distinct Deletions with Five Recurrent Breakpoints
Background: Large genomic rearrangements (LGR) in BRCA1 consisting of deletions/duplications of one or several exons have been found throughout the gene with a large proportion occurring in the 5′ region from the promoter to exon 2. The aim of this study was to better characterize those LGR in French high-risk breast/ovarian cancer families. Methods: DNA from 20 families with one apparent duplication and nine deletions was analyzed with a dedicated comparative genomic hybridization (CGH) array, high-resolution BRCA1 Genomic Morse Codes analysis and Sanger sequencing. Results: The apparent duplication was in fact a tandem triplication of exons 1 and 2 and part of intron 2 of BRCA1, fully characterized here for the first time. We calculated a causality score with the multifactorial model from data obtained from six families, classifying this variant as benign. Among the nine deletions detected in this region, eight have never been identified. The breakpoints fell in six recurrent regions and could confirm some specific conformation of the chromatin. Conclusions: Taken together, our results firmly establish that the BRCA1 5′ region is a frequent site of different LGRs and highlight the importance of the segmental duplication and Alu sequences, particularly the very high homologous region, in the mechanism of a recombination event. This also confirmed that those events are not systematically deleterious.